Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ore Pharmaceuticals, a drug development company, has appointed Mark Gabrielson as its new president and CEO, replacing Charles Dimmler, III.
Subscribe to our email newsletter
Mr Gabrielson presently serves on the company’s board of directors and, most recently, was managing general partner of p-Value Capital, a specialty financial services firm.
Mr Gabrielson also serves on the board of directors of Pulmatrix, a private pharmaceutical company that he co-founded in 2003 and where he was CEO from its founding through 2007.
Mr Gabrielson also was a general partner of Prince Ventures, a healthcare venture capital firm. Mr Gabrielson began his career at GlaxoSmithKline.